Prostate Cancer Information and Treatments

Prostate cancer information and treatments are provided solely for education and awareness purposes. Patients should consult their medical doctor for advice and recommendations about specific treatments. PHEN does not provide medical advice or recommendations to patients about treatments.

Information
The Prostate

General information about the prostate and prostate cancer, including the stages of prostate cancer and treatment options.

Information
Treatments Overview

An overview and description of treatments for prostate cancer

Information
 
Your Prostate Cancer is Unique

Every man is different and every prostate cancer is unique. Are you making the most informed treatment decision?

Information
Hormone Therapy for Prostate Cancer (Fact Sheet)

Hormones are substances made by glands in the body that function as chemical signals.

Information
 
My Prostate Cancer RoadMap

Put Yourself In The Driver's Seat To Managing Advanced Prostate Cancer

Information
XTANDI Patient Financial Support

XTANDI Support Solutions is a single point of contact to help patients understand their coverage and reimbursement options for XTANDI.

Information
 
Augmenix SpaceOar
Augmenix
SpaceOAR System reduces rectal injury in men receiving prostate cancer radiation therapy (RT) by acting as a spacer – pushing the rectum away from the prostate.

Information
Bone Health In Focus - Patients

Understanding The Importance Of Bone Health When Living With Metastatic Prostate Cancer

Information
 
Bone Health In Focus - Caregivers

Understanding The Importance Of Bone Health When Caring For Someone Living With Metastatic Cancer

Information
Bone Health In Focus

The Effects Of Metastatic Cancer On Your Bones

Information
 
Advocacy Connector

Connecting patients and caregivers with resources.

Information
Smoking Risks

Smoking is a risk factor for biochemical recurrence of prostate cancer following radical prostatectomy. Study findings suggest that current and former smokers have a significant 1.8 and 1.6 times higher risk of biochemical recurrence than non-smokers.

Information
 
Treatments
XTANDI® (enzalutamide)
XTANDI® (enzalutamide)
For patients with metastatic castration-resistant prostate cancer who have previously received docetaxel

Information
Provenge - Active Cellular Immunotherapy

A new treatment for advanced prostate cancer patients approved by the Food and Drug Administration (FDA) in April 2010

Information
 
XOFIGO, radium Ra 223 dichloride

For the treatment of patients with castration - resistant prostate cancer (CRPC), symtomatic bone metastases and no known visceral metastatic disease.

Information
ZYTIGA™

ZYTIGA (abiraterone acetate) in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy containing docetaxel.

Information
 
AMGEN XGEVA™
AMGEN
The National Comprehensive Cancer Network (NCCN) recommends that patients with bone metastases should be treated with bone-targeting medication to prevent bone complications. XGEVA™ is an Amgen prescription medication approved by the FDA

Information
Cyberknife Stereotactic Radiation
Cyberknife
The CyberKnife System is the world’s first and only robotic radiosurgery system designed to treat tumors throughout the body non-invasively.

Information
 
ProstRcision®

ProstRcision® (pronounced PROS-ter-si-shun) is a unique technique for curing prostate cancer which uses a combination seed implants and conformal beam irradiation to simultaneously destroy the prostate and prostate cancer from within, in addition to targeting surrounding tissue for possible microscopic capsule penetration.

Information
VA Choice Program and the CyberKnife® System

Dedicated to informing United States military veterans about a program that allows veterans to access treatment outside of Veterans Health Administration facilities (through the VA Choice Program)

Information
 
















PHEN,Inc. © 2018 All rights reserved